Nuvera's 'The PURE Report' Announces the Best-in-Class Pharmaceutical Support Programs for 2021 in Neurology and Oncology

Best Pharma Support Program Neurology & Oncology 2021

Nuvera Life Science Consulting, an expert advisor on patient-centric experiences for specialty therapeutics, has announced the best-in-class pharma patient support programs in Neurology and Oncology for 2021. This is the third installment of Nuvera's groundbreaking PURE Report series — the industry's first independent, standardized assessment of healthcare provider (HCP) satisfaction with patient support programs.

The PURE Report uses a unique blend of variables to holistically evaluate support programs based on HCP responses. This proprietary algorithm determines the best-in-class programs based on aided and unaided inputs from about 500 MDs and support staff from each therapeutic area.

The PURE Report: 2021 Neurology awarded Biogen as having the best-in-class program in Neurology, which was announced at Informa's Patient Support Services Congress on June 15, 2021. Biogen's success with the physicians gave them a distinct edge against competitors, though they did perform well among support staff as well.

For the PURE Report: 2021 Oncology, Pfizer was singled out as having the best-in-class program in Oncology. Pfizer's success comes as a result of recent popularity amongst practices' support staff, giving them the win in the highly competitive oncology marketplace.

The PURE Report's comprehensive analysis consists of two separate parts: a syndicated research report that interprets data on HCP perceptions of various program interactions, their service expectations, and their preferred manufacturer programs; and a company-specific report, which analyzes manufacturer rankings across the seven PURE indices, with a spotlight on individual companies.

"This is the third year we are running this research; we've collected almost 3,000 responses to date, which is a wealth of benchmarking data," said Nuvera's Jens Kulstad, who spearheaded the research. "The PURE Report: Neurology 2021 and Oncology 2021 allows us to comprehensively compare company performance and award a best-in-class company. We can also compare results against previous years and see how they are changing over time."

The PURE Report: Neurology 2021 and Oncology 2021 is soon available for industry. Nuvera will present highlights from the research at upcoming conferences. For additional information, please see or

About Nuvera Life Science Consulting

Nuvera Life Science Consulting helps the world's leading pharmaceutical and biotech companies deliver impactful patient and HCP support experiences for specialty and rare-disease therapies. Nuvera excels at uncovering patient/HCP needs and crafting and helping execute seamless treatment experiences that enhance patients' ability to obtain, start, and stay on therapies. To learn more, please visit

The PURE Report

Jens Kulstad
Manager, PURE Report

Source: Nuvera Life Science Consulting